Related Experiment Video
Updated: Jun 26, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy
1Department of Oncology, The Queen Elizabeth Hospital, Adelaide, Australia.
Abstract:
Abstract Hyperammonaemic encephalopathy has been infrequently reported after both standard and high-dose chemotherapy for solid and haematological malignancies. It is important to consider this diagnosis for patients with unexplained behaviour changes or encephalopathy and this case report emphasizes this condition and the importance of early diagnosis and is the first reported in association with rituximab-containing chemotherapy.
Related Concept Videos
Hepatic Encephalopathy
Cryptococcal Meningitis
Encephalitis l: Introduction
Rocky Mountain Spotted Fever
Encephalitis ll: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy